ASGR1 and hepatocellular carcinoma: Leveraging this specificity, we designed XZ1606 to selectively engage ASGPR for enhanced hepatic uptake (Figure 1E), with its exact chemical structure detailed in Figure S1A. XZ1606 was originally developed for HCC 40.